| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3039829 | Clinical Neurology and Neurosurgery | 2015 | 6 Pages |
Abstract
Our study depicts that patients eligible for repeat-surgery at GB recurrence are characterized by a KPS > 70% before primary and repeat-surgery, Charlson-comorbidity-index â¤Â 3, large tumor size and young age. These well-selected patients survive significantly longer after repeat-surgery without being at a higher complication risk in comparison to patients not operated upon.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Genevieve Ening, Mai Thi Huynh, Kirsten Schmieder, Christopher Brenke,